Furthermore, when subjects with IL-13Rα2 low (n = 113) and IL-13Rα2 negative (n = 122) tumor groups were combined together (n = 235), the median survival was significantly higher compared to subjects with high IL-13Rα2 expressing tumors (p < 0.003) (Fig. 2b). Here, IL13RA2 is linked to neoplasm.